Corporate News AbbVie in charts: Skyrizi, Rinvoq sales jump, while Humira revenue falls ~30% Y/Y in Q2 by Contributor since / Followers 4 months ago Tags: ABBV Continue Reading Previous Earnings summary: AbbVie reports mixed Q2 results; raises FY24 EPS outlookNext Royal Caribbean boosts profit guidance and reinstates dividend as bookings stay strong Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
